TriSalus Life Sciences, Inc.

NASDAQ:TLSI

Medical - Devices

Healthcare
$2.18 +0.49%

+$0.02 today

Market cap
$134.20M
Beta
0.49
P/E (TTM)
-7.4
EPS (TTM)
-$0.53
52W Low $2.20High $7.95

Volume 0.36M

Average 0.38M

Balance Sheet

Inspect the capital base behind the business.

Assets

$35.33M

FY 2025 · Annual

+47.4% YoY

Liabilities

$69.19M

FY 2025 · Annual

+38.8% YoY

Equity

-$33.86M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents30.3M9.41M11.78M8.53M20.44M
Short-term Investments00000
Net Receivables1.36M1.56M3.55M5.09M6.56M
Inventory1.29M1.47M2.55M4.05M3.08M
Other Current Assets00000
Total Current Assets35.13M17.21M20.86M20.67M32.24M
Property, Plant & Equipment (Net)1.8M3.61M3.27M2.88M2.67M
Goodwill00000
Intangible Assets794K802K000
Long-term Investments0250K0350K400K
Tax Assets00000
Other Non-current Assets115K117K466K73K18K
Total Non-current Assets2.71M4.78M3.74M3.3M3.09M
Total Assets37.84M22M24.6M23.97M35.33M
Account Payables1.3M4.95M3.39M2.27M3M
Short-term Debt0370K00167K
Tax Payables00034K0
Deferred Revenue00000
Other Current Liabilities104K23.57M420K383K8.23M
Total Current Liabilities6.37M32.36M14.69M10.23M11.5M
Long-term Debt00022.08M34.27M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities561K369K35.73M16.22M23.42M
Total Non-current Liabilities561K1.96M36.98M39.64M57.69M
Total Liabilities6.93M34.32M51.66M49.87M69.19M
Common Stock11K02K3K4K
Retained Earnings(136.34M)(186.36M)(249.5M)(279.55M)(330.58M)
Accumulated OCI00(0)00
Other Stockholders Equity00000
Minority Interest00000
Total Equity30.9M(12.32M)(27.07M)(25.89M)(33.86M)
Total Debt01.96M1.6M23.63M34.44M
Net Debt(30.3M)(7.45M)(10.18M)15.1M14M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$56.6M
Receivables$5.2M
Inventory$3.8M
Other Current$2.6M
Total Current Assets$68.1M
PP&E (Net)$2.8M
Other Non-current$69.0K
Total Non-current Assets$2.8M
Total Assets$71.0M

Analysis

Selected assets total $71.0M for Latest. The largest visible component is Cash & Equivalents at $56.6M, about 79.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
4Statement of changes in beneficial ownershipOct 7, 2026
4Statement of changes in beneficial ownershipOct 7, 2026
4Statement of changes in beneficial ownershipOct 7, 2026

How much cash does TLSI have?

TriSalus Life Sciences, Inc. (TLSI) reported $20.44M in cash and equivalents in fiscal 2025.

How much debt does TLSI carry?

TriSalus Life Sciences, Inc. (TLSI) reported $34.44M of total debt, with net debt of $14.00M.